Recent Articles

Ksana Health partners with Beckley PsyTech!

At Ksana Health, we provide our continuous behavior measurement platform (CBHM), Effortless Assessment of Risk States (EARS), to clinical researchers. This platform has given them richer insight into the passive behavior of...

Continue reading

Psychedelic Drug MDMA Shows Promise as Treatment for PTSD

Continue reading

Ksana Health at SXSW 2022

Trip Planning: Psychedelics and Digital Therapies March 16, 2022 · 11:30 a.m. Ksana Health’s CEO and Co-Founder Dr. Nick Allen is participating in a panel discussion on recent innovations in mental health...

Continue reading